Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

February 4, 2026 Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST ...

February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models ...

Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, And Forecasts To 2031. The Global Diagnostic Enzymes Market is driven by rising chronic disease prevalence ...

Rochester, N.Y. (WHAM) — Kodak has announced an expansion of its pharmaceuticals portfolio with four new regulated products.

ABSTRACT: Species of the genus Desmodium are generally used in the traditional Beninese pharmacopoeia for the treatment of many diseases, including infectious diseases. The objective of this work is ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it.

A first-of-its-kind small molecule selectively degrades the cancer-linked RNA TERRA in cells, slowing tumor growth and showcasing a promising RNA-targeted strategy beyond traditional protein-focused ...

Recently, a research team led by Professor Zhengping Xu of Zhejiang University School of Medicine and its affiliated Sir Run Run Shaw Hospital published a paper in Science Bulletin titled ...

Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia The concept of utilizing synthetic nucleic acids and their conjugates with ...